Breakthrough invasive fungal infections: Who is at risk?

Loading...
Thumbnail Image

Date

2020-10

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

4
views
24
downloads

Citation Stats

Abstract

The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs. Although this strategy has resulted in an overall reduction in IFIs, a subset of patients develop breakthrough IFIs with substantial morbidity and mortality in this population. Here, we review the most significant risk factors for breakthrough IFIs in haematology patients, solid organ transplant recipients, and patients in the intensive care unit, focusing particularly on host factors, and highlight areas that require future investigation.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1111/myc.13148

Publication Info

Jenks, Jeffrey D, Oliver A Cornely, Sharon C-A Chen, George R Thompson and Martin Hoenigl (2020). Breakthrough invasive fungal infections: Who is at risk?. Mycoses, 63(10). pp. 1021–1032. 10.1111/myc.13148 Retrieved from https://hdl.handle.net/10161/28612.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.